WP
NVS icon

WealthSource Partners’s Novartis NVS Stock Holding History

WealthSource Partners’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$498K Sell
4,936
-625
-11% -$60.3K 0.03% 319
2023
Q3 		$566K Sell
5,561
-61
-1% -$6.19K 0.04% 278
2023
Q2 		$567K Sell
5,622
-3,731
-40% -$373K 0.04% 294
2023
Q1 		$860K Sell
9,353
-60
-0.6% -$5.24K 0.06% 213
2022
Q4 		$854K Buy
9,413
+5,053
+116% +$426K 0.06% 220
2022
Q3 		$331K Sell
4,360
-2,344
-35% -$194K 0.02% 373
2022
Q2 		$567K Sell
6,704
-1,155
-15% -$101K 0.04% 285
2022
Q1 		$690K Sell
7,859
-310
-4% -$26.8K 0.05% 282
2021
Q4 		$715K Buy
8,169
+262
+3% +$21.8K 0.06% 250
2021
Q3 		$647K Buy
7,907
+50
+0.6% +$4.5K 0.06% 242
2021
Q2 		$717K Sell
7,857
-1,515
-16% -$135K 0.06% 216
2021
Q1 		$801K Sell
9,372
-349
-4% -$31.3K 0.08% 183
2020
Q4 		$918K Sell
9,721
-25
-0.3% -$2.19K 0.11% 131
2020
Q3 		$848K Sell
9,746
-581
-6% -$50.3K 0.11% 120
2020
Q2 		$902K Buy
10,327
+1,234
+14% +$107K 0.13% 102
2020
Q1 		$750K Buy
9,093
+1,444
+19% +$129K 0.12% 128
2019
Q4 		$724K Buy
7,649
+5,002
+189% +$449K 0.1% 176
2019
Q3 		$230K Sell
2,647
-282
-10% -$25.3K 0.03% 376
2019
Q2 		$267K Buy
+2,929
New +$248K 0.04% 361
2018
Q1 		– Sell
-3,164
Closed -$238K – 318
2017
Q4 		$238K Buy
3,164
+200
+7% +$15.1K 0.07% 251
2017
Q3 		$228K Sell
2,964
-275
-8% -$20.8K 0.08% 250
2017
Q2 		$242K Sell
3,239
-357
-10% -$25.3K 0.08% 231
2017
Q1 		$239K Buy
3,596
+504
+16% +$33.6K 0.09% 225
2016
Q4 		$202K Sell
3,092
-110
-3% -$7.14K 0.09% 227
2016
Q3 		$227K Sell
3,202
-42
-1% -$3.06K 0.08% 221
2016
Q2 		$240K Buy
3,244
+42
+1% +$2.9K 0.09% 209
2016
Q1 		$208K Buy
+3,202
New +$218K 0.08% 207

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

WealthSource Partners's NVS Position: Q4 2023 in Review

WealthSource Partners reduced its Novartis (NVS) stake by 11% in Q4 2023, selling an estimated $60.3K and leaving 4,936 shares worth $498K. The position accounts for 0.03% of the portfolio, ranked #319.

WealthSource Partners first reported a position in NVS in Q1 2016 and has held it in 27 quarters since. The position peaked at $918K in Q4 2020. 1,272 funds tracked by Wall St. Rank hold NVS as of Q4 2023.

  • WealthSource Partners held 4,936 shares of Novartis worth $498K as of Q4 2023.
  • WealthSource Partners sold 625 Novartis shares in Q4 2023, an estimated $60.3K.
  • Novartis made up 0.03% of WealthSource Partners's portfolio in Q4 2023, its #319 holding.
  • WealthSource Partners first reported a position in Novartis in Q1 2016 and has held it in 27 quarters since.
  • WealthSource Partners's Novartis position peaked at $918K in Q4 2020.
  • 1,272 funds tracked by Wall St. Rank held Novartis as of Q4 2023.

Based on WealthSource Partners's 13F filing for Q4 2023, filed 16 Jan 2024.